Myasthenia gravis as a 'stroke mimic'--it's all in the history

Saiffuddin Shaik1, Mian Ayaz Ul-Haq1, Hedley C A Emsley2

  • 1Department of Neurology, Royal Preston Hospital, Preston, UK;

Insights

This case highlights a diagnostic challenge in an elderly patient presenting with acute swallowing and speech difficulties. Prompt clinical assessment is crucial for accurately diagnosing myasthenia gravis, especially in older adults.

Area of Science:

  • Neurology
  • Geriatrics

Background:

  • Myasthenia gravis is a rare neuromuscular disorder, more prevalent in the elderly.
  • Distinguishing myasthenia gravis from stroke can be challenging due to overlapping symptoms like dysphagia and dysarthria.

Observation:

  • An 85-year-old male presented with acute onset dysphagia and dysarthria, initially suspected as stroke.
  • Patient's reported fatigability and diurnal symptom variation suggested myasthenia gravis.

Findings:

  • The case underscores the complexity of diagnosing myasthenia gravis in the acute setting, particularly in elderly patients.
  • Diagnostic interpretation was complicated by the patient's turbulent clinical course.

Implications:

  • Accurate and timely clinical assessment is vital for correct diagnosis and management of neuromuscular disorders.
  • Adherence to established clinical diagnostic formulations aids in managing complex neurological presentations in older adults.

Related Concept Videos

Myasthenia Gravis: Overview and Treatment01:20

Myasthenia Gravis: Overview and Treatment

Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
3.7K
Myasthenia Gravis: Diagnostic Tests01:15

Myasthenia Gravis: Diagnostic Tests

Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
3.3K
Myasthenia Gravis ll: Pathophysiology01:22

Myasthenia Gravis ll: Pathophysiology

The disease process of myasthenia gravis begins at the neuromuscular junction, where antibodies attack key proteins needed for muscle activation. This immune reaction weakens signal transmission, leading to the characteristic muscle fatigue and weakness that define the condition.Immune-Mediated DamageIn most individuals, antibodies target acetylcholine receptors (AChRs) on the postsynaptic membrane of muscle cells. By blocking acetylcholine binding, these antibodies prevent the nerve signal...
14
Disorders of the Skeletal Muscle01:28

Disorders of the Skeletal Muscle

The clinical conditions affecting the skeletal muscle tissue are broadly categorized as musculoskeletal and neuromuscular disorders.
Musculoskeletal disorders
Musculoskeletal disorders involve injuries and conditions affecting the skeletal muscles and associated connective tissues. These disorders can arise from acute biomechanical stresses or chronic overuse and can occur across different age groups. Common injuries include sprains, fractures, and muscular strains, often resulting from...
2.4K
Chemical Synapses01:26

Chemical Synapses

Chemical synapses are specialized sites between two neurons or between a neuron and a non-neuronal cell like a muscle, glandular or sensory cell.
Because chemical synapses depend on the release of neurotransmitter molecules from synaptic vesicles to pass on their signal, there is an approximately one millisecond delay between when the axon potential reaches the presynaptic terminal and when the neurotransmitter leads to opening of postsynaptic ion channels. Additionally, this signaling is...
12.9K
Chemical Synapses01:26

Chemical Synapses

Chemical synapses are specialized sites between two neurons or between a neuron and a non-neuronal cell like a muscle, glandular or sensory cell.
Because chemical synapses depend on the release of neurotransmitter molecules from synaptic vesicles to pass on their signal, there is an approximately one millisecond delay between when the axon potential reaches the presynaptic terminal and when the neurotransmitter leads to opening of postsynaptic ion channels. Additionally, this signaling is...
10.7K